Home › NDC Lookup › RxCUI directory › RxCUI 977860

Methamphetamine hydrochloride 5 MG Oral Tablet — RxCUI 977860

RxNorm drug concept · Semantic clinical drug
RxCUI 977860 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI977860
Official nameMethamphetamine hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethamphetamine HCl 5 MG Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)281 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methamphetamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Methamphetamine tablets are prescribed for ADHD in children over 6. They work best as one part of a bigger plan that includes behavioral, educational and social support.
  • It is taken by mouth once a day or split into two doses. Try to avoid taking it late in the evening because it can keep you awake. Follow your prescriber's directions and the label...
  • Common ones include a pounding heartbeat, dizziness, trouble sleeping, shakiness, headache, diarrhea and dry mouth. Call your prescriber if you notice chest pain, fainting, halluci...
  • Yes. It must not be used with MAOI antidepressants or within 14 days of stopping one. Tell me about any antidepressants, migraine medicines, tramadol, lithium, St. John's Wort, ant...
📖 Read our full Methamphetamine guide →

🕸️ Concept Web — How Methamphetamine hydrochloride 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methamphetamine hydrochloride 5 MG Oral Tablet RxCUI 977860

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Methamphetamine 6816
    • Methamphetamine hydrochloride 82044
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Desoxyn 224965
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methamphetamine Oral Tablet 372809
    • Methamphetamine hydrochloride Oral Tablet 2649365
    • Methamphetamine Oral Product 1161627
    • Methamphetamine Pill 1161628
    • Methamphetamine hydrochloride Oral Product 2660072
    • Methamphetamine hydrochloride Pill 2660818
    • Methamphetamine Oral Tablet [Desoxyn] 369057
    • Methamphetamine hydrochloride Oral Tablet [Desoxyn] 2657370
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Methamphetamine hydrochloride 5 MG 977856
    • Methamphetamine hydrochloride 5 MG Oral Tablet [Desoxyn] 977861
    • Methamphetamine hydrochloride 5 MG [Desoxyn] 977858

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methamphetamine hydrochloride 5 MG SCDC · 977856
  • Methamphetamine Oral Tablet SCDF · 372809
  • Methamphetamine hydrochloride Oral Tablet SCDFP · 2649365
  • Methamphetamine Oral Product SCDG · 1161627
  • Methamphetamine Pill SCDG · 1161628
  • Methamphetamine hydrochloride Oral Product SCDGP · 2660072
  • Methamphetamine hydrochloride Pill SCDGP · 2660818

Brand-Name Concepts

  • Methamphetamine hydrochloride 5 MG Oral Tablet [Desoxyn] SBD · 977861
  • Methamphetamine hydrochloride 5 MG [Desoxyn] SBDC · 977858
  • Methamphetamine Oral Tablet [Desoxyn] SBDF · 369057
  • Methamphetamine hydrochloride Oral Tablet [Desoxyn] SBDFP · 2657370
  • Desoxyn Oral Product SBDG · 1174522
  • Desoxyn Pill SBDG · 1174523
  • Desoxyn BN · 224965

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 977860 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0389-25 100 TABLET in 1 BOTTLE (0054-0389-25) Methamphetamine Hydrochloride Hikma Pharmaceuticals USA Inc. 2016-12-06
68308-0115-01 100 TABLET in 1 BOTTLE, PLASTIC (68308-115-01) Methamphetamine Hydrochloride Mayne Pharma Commercial LLC 2010-04-26
75907-0094-01 100 TABLET in 1 BOTTLE, PLASTIC (75907-094-01) Methamphetamine Hydrochloride Dr. Reddy's Laboratories Inc 2025-11-07
Observed labelers: Dr. Reddy's Laboratories Inc (1) · Hikma Pharmaceuticals USA Inc. (1) · Mayne Pharma Commercial LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$5.4532
Range $5.4532–$5.4532 · middle 50% $5.4532–$5.4532 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.